CN117431171A - Lactobacillus brevis for inhibiting mold and adsorbing and degrading aflatoxin B1 and application thereof - Google Patents
Lactobacillus brevis for inhibiting mold and adsorbing and degrading aflatoxin B1 and application thereof Download PDFInfo
- Publication number
- CN117431171A CN117431171A CN202311056688.0A CN202311056688A CN117431171A CN 117431171 A CN117431171 A CN 117431171A CN 202311056688 A CN202311056688 A CN 202311056688A CN 117431171 A CN117431171 A CN 117431171A
- Authority
- CN
- China
- Prior art keywords
- afb1
- strain
- lactobacillus brevis
- detoxification
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 title claims abstract description 91
- 229930020125 aflatoxin-B1 Natural products 0.000 title claims abstract description 91
- 239000002115 aflatoxin B1 Substances 0.000 title claims abstract description 89
- 240000001929 Lactobacillus brevis Species 0.000 title claims abstract description 41
- 235000013957 Lactobacillus brevis Nutrition 0.000 title claims abstract description 41
- 230000002401 inhibitory effect Effects 0.000 title description 6
- 230000000593 degrading effect Effects 0.000 title 1
- 238000009629 microbiological culture Methods 0.000 claims abstract description 3
- 239000003674 animal food additive Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims 1
- 238000001784 detoxification Methods 0.000 abstract description 43
- 239000004460 silage Substances 0.000 abstract description 19
- 238000001179 sorption measurement Methods 0.000 abstract description 17
- 230000012010 growth Effects 0.000 abstract description 15
- 239000002253 acid Substances 0.000 abstract description 12
- 210000002421 cell wall Anatomy 0.000 abstract description 10
- 239000002054 inoculum Substances 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 238000005406 washing Methods 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 101100449517 Arabidopsis thaliana GRH1 gene Proteins 0.000 abstract 2
- 101100434479 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AFB1 gene Proteins 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 64
- 241000894006 Bacteria Species 0.000 description 34
- 235000014655 lactic acid Nutrition 0.000 description 32
- 239000004310 lactic acid Substances 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 27
- 230000001580 bacterial effect Effects 0.000 description 23
- 239000000243 solution Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 19
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 14
- 239000002953 phosphate buffered saline Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 241000233866 Fungi Species 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 239000003053 toxin Substances 0.000 description 8
- 231100000765 toxin Toxicity 0.000 description 8
- 108700012359 toxins Proteins 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 231100000678 Mycotoxin Toxicity 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 239000002636 mycotoxin Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000016943 Muramidase Human genes 0.000 description 5
- 108010014251 Muramidase Proteins 0.000 description 5
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 229960000274 lysozyme Drugs 0.000 description 5
- 235000010335 lysozyme Nutrition 0.000 description 5
- 239000004325 lysozyme Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000009630 liquid culture Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 241000228197 Aspergillus flavus Species 0.000 description 3
- 241000228230 Aspergillus parasiticus Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 238000010170 biological method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000001965 potato dextrose agar Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/28—Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/24—Lactobacillus brevis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明属于微生物应用技术领域,尤其涉及一种抑制霉菌和吸附降解黄曲霉毒素B1的短乳杆菌及其应用。该短乳杆菌(Lactobacillus brevis)ND‑1已于2023年6月20日保藏在中国微生物菌种保藏管理委员会普通微生物中心,其简称为CGMCC,保藏编号为NO.27664。本发明提供的短乳杆菌(Lactobacillus brevis)ND‑1主要通过细胞壁的物理吸附作用去除AFB1,在PBS溶液中脱毒效率为71.38%。菌株DN‑1具有良好的生长速率及产酸性能,可以作为青贮接种剂的备选菌株。在洗涤3次后,脱毒率仍保持高效。菌株DN‑1脱毒AFB1的最适条件为:接种量2.5%,初始pH6.0,温度36℃,培养时间4h。
The invention belongs to the field of microbial application technology, and particularly relates to a Lactobacillus brevis that inhibits mold and adsorbs and degrades aflatoxin B1 and its application. The Lactobacillus brevis ND‑1 has been deposited in the General Microbiology Center of the China Microbial Culture Collection Committee on June 20, 2023. Its abbreviation is CGMCC, and the deposit number is NO. 27664. Lactobacillus brevis ND-1 provided by the present invention mainly removes AFB1 through physical adsorption of the cell wall, and its detoxification efficiency in PBS solution is 71.38%. Strain DN‑1 has good growth rate and acid production performance and can be used as an alternative strain for silage inoculants. After washing 3 times, the detoxification rate remains highly efficient. The optimal conditions for strain DN‑1 to detoxify AFB1 are: inoculum volume 2.5%, initial pH 6.0, temperature 36°C, and culture time 4 hours.
Description
技术领域Technical field
本发明属于微生物应用技术领域,尤其涉及一种抑制霉菌和吸附降解黄曲霉毒素B1的短乳杆菌及其应用。The invention belongs to the field of microbial application technology, and particularly relates to a Lactobacillus brevis that inhibits mold and adsorbs and degrades aflatoxin B1 and its application.
背景技术Background technique
黄曲霉毒素B1(AFB1)主要是由黄曲霉和寄生曲霉等真菌产生的次级代谢产物,广泛存在于食品及饲料中。AFB1是迄今为止发现的性质最稳定、毒性最强的霉菌毒素,长期摄入可引发肝癌,并引起其他器官如肾、肺、胃肠等癌变,已经被国际癌症研究机构归为Ⅰ级致癌物。近年来,关于青贮饲料中AFB1污染造成重大损失的相关报道也在增加。青贮饲料是奶牛和肉牛等反刍动物日粮最为重要的组成部分,占总日粮的50-75%,主要通过乳酸菌在厌氧条件下产生有机酸来降低饲料pH,从而抑制有害菌增殖,有储存时间长、营养价值高等优点。相比于其它常规饲料,青贮饲料由于其贮藏环境的高温高湿更容易受到AFB1的污染。一项调查显示,玉米青贮饲料是检出毒素的主要来源,且对奶牛霉菌毒素摄入的影响是其他饲料的3倍。奶牛和肉牛等反刍动物采食被AFB1污染的青贮饲料会损害机体健康,容易引起免疫力降低、产奶量减少、生殖和发育障碍等问题,且随着采食时间的延长,危害越大。Aflatoxin B1 (AFB1) is a secondary metabolite mainly produced by fungi such as Aspergillus flavus and Aspergillus parasiticus, and is widely present in food and feed. AFB1 is the most stable and toxic mycotoxin discovered so far. Long-term intake can cause liver cancer and cause cancer in other organs such as kidneys, lungs, gastrointestinal tract, etc. It has been classified as a Class I carcinogen by the International Agency for Research on Cancer. . In recent years, reports of significant losses caused by AFB1 contamination in silage have also increased. Silage is the most important component of the diet of ruminants such as dairy cows and beef cattle, accounting for 50-75% of the total diet. It mainly uses lactic acid bacteria to produce organic acids under anaerobic conditions to reduce the feed pH, thereby inhibiting the proliferation of harmful bacteria, and has It has the advantages of long storage time and high nutritional value. Compared with other conventional feeds, silage is more susceptible to AFB1 contamination due to the high temperature and humidity of its storage environment. A survey showed that corn silage is the main source of detected toxins and has three times the impact on mycotoxin intake in dairy cows than other feeds. When ruminants such as dairy cows and beef cattle eat silage contaminated with AFB1, it will damage the body's health and easily cause problems such as reduced immunity, reduced milk production, reproductive and developmental disorders, and the harm will become greater as the feeding time is extended.
目前来说,去除食品及饲料中AFB1的方法主要分为物理法、化学法和生物法等三种方法。物理方法主要包括紫外线、电离辐射等;化学方法是用能够破坏霉菌毒素结构的试剂。这些方法长期使用会促使产毒真菌产生耐药性,并且成本高、损害环境和人类健康等问题限制了其应用。不同于前两个方法,生物法主要是通过微生物本身和其分泌物达到脱毒效果,即微生物的降解作用和吸附作用,基于这一绿色安全的特性生物法被广泛研究应用。在青贮饲料生产中乳酸菌常被用作饲料添加剂,同时关于乳酸菌脱除AFB1的研究不断增加,表明了乳酸菌在去除AFB1方面的巨大潜力。在脱除AFB1方面,Zhu等从发酵食品中分离出一株植物乳杆菌,对AFB1的脱毒率为89.5%。Guan等从中国西南地区的牧草和青贮饲料中分离出鼠李糖乳杆菌(Lactobacillus rhamnosus)XH753,将该菌株接种到青贮饲料上可以延长有氧稳定性并降低AFB1的含量。At present, the methods for removing AFB1 from food and feed are mainly divided into three methods: physical method, chemical method and biological method. Physical methods mainly include ultraviolet light, ionizing radiation, etc.; chemical methods use reagents that can destroy the structure of mycotoxins. Long-term use of these methods will promote the development of drug resistance in toxin-producing fungi, and problems such as high cost and damage to the environment and human health limit their application. Different from the first two methods, biological methods mainly achieve detoxification effects through the microorganisms themselves and their secretions, that is, the degradation and adsorption of microorganisms. Based on this green and safe characteristic, biological methods have been widely researched and applied. Lactic acid bacteria are often used as feed additives in silage production, and research on the removal of AFB1 by lactic acid bacteria continues to increase, indicating the great potential of lactic acid bacteria in removing AFB1. In terms of removing AFB1, Zhu et al. isolated a strain of Lactobacillus plantarum from fermented food, and the detoxification rate of AFB1 was 89.5%. Guan et al. isolated Lactobacillus rhamnosus XH753 from pasture and silage in southwest China. Inoculation of this strain into silage can prolong aerobic stability and reduce AFB1 content.
乳酸菌作为一种安全的生物添加剂已经获得认证。关于乳酸菌作为青贮饲料添加剂的研究也在不断增加,这些乳酸菌的来源通常是发酵食品及动物肠道,然而在霉菌毒素污染的青贮饲料及采食霉菌毒素的青贮饲料的牛粪便中筛选具有脱毒AFB1的乳酸菌的研究鲜有报道。Lactic acid bacteria have been certified as a safe biological additive. Research on lactic acid bacteria as silage additives is also increasing. The sources of these lactic acid bacteria are usually fermented foods and animal intestines. However, screening of mycotoxin-contaminated silage and cow feces that consume mycotoxin-contaminated silage has detoxification properties. Research on AFB1 lactic acid bacteria has rarely been reported.
发明内容Contents of the invention
本发明针对黄曲霉毒素B1的去除所存在的技术问题,提出一种抑制霉菌和吸附降解黄曲霉毒素B1的短乳杆菌及其应用。In view of the technical problems existing in the removal of aflatoxin B1, the present invention proposes a Lactobacillus brevis that inhibits mold and adsorbs and degrades aflatoxin B1 and its application.
为了达到上述目的,本发明采用的技术方案为:In order to achieve the above objects, the technical solutions adopted by the present invention are:
本发明提供一种短乳杆菌(Lactobacillus brevis)ND-1,该短乳杆菌(Lactobacillus brevis)ND-1已于2023年6月20日保藏在中国微生物菌种保藏管理委员会普通微生物中心,其简称为CGMCC,地址为 北京市朝阳区北辰西路1号院3号保藏编号为CGMCC No.27664。The present invention provides Lactobacillus brevis ND-1. The Lactobacillus brevis ND-1 has been deposited in the General Microbiology Center of the China Microbial Culture Collection Committee on June 20, 2023, and its abbreviation is It is CGMCC, and its address is No. 3, No. 1, Beichen West Road, Chaoyang District, Beijing. The collection number is CGMCC No. 27664.
该短乳杆菌(Lactobacillus brevis)ND-1在制备抑制黄曲霉毒素B1的饲料添加剂中应用。The Lactobacillus brevis ND-1 is used in the preparation of feed additives that inhibit aflatoxin B1.
该短乳杆菌(Lactobacillus brevis)ND-1在制备吸附降解黄曲霉毒素B1的短乳杆菌的饲料添加剂中应用。The Lactobacillus brevis ND-1 is used in preparing feed additives for Lactobacillus brevis that adsorb and degrade aflatoxin B1.
本发明还提供一种饲料添加剂,包含上述的短乳杆菌(Lactobacillus brevis)ND-1的活细胞或热灭活细胞。The present invention also provides a feed additive containing the above-mentioned living cells or heat-killed cells of Lactobacillus brevis ND-1.
与现有技术相比,本发明的优点和积极效果在于:Compared with the existing technology, the advantages and positive effects of the present invention are:
本发明提供的短乳杆菌(Lactobacillus brevis)ND-1主要通过细胞壁的物理吸附作用去除AFB1,在PBS溶液中脱毒效率为71.38%。菌株DN-1具有良好的生长速率及产酸性能,可以作为青贮接种剂的备选菌株。在洗涤3次后,脱毒率仍保持高效。菌株DN-1脱毒AFB1的最适条件为:接种量2.5%,初始pH6.0,温度36℃,培养时间4h。Lactobacillus brevis ND-1 provided by the invention mainly removes AFB1 through physical adsorption of the cell wall, and its detoxification efficiency in PBS solution is 71.38%. Strain DN-1 has good growth rate and acid production performance, and can be used as an alternative strain for silage inoculant. After washing 3 times, the detoxification rate remains highly efficient. The optimal conditions for strain DN-1 to detoxify AFB1 are: inoculum volume 2.5%, initial pH 6.0, temperature 36°C, and culture time 4 hours.
附图说明Description of the drawings
为了更清楚地说明本发明实施例的技术方案,下面将对实施例描述中所需要使用的附图作一简单地介绍,显而易见地,下面描述中的附图是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其他的附图。In order to explain the technical solutions of the embodiments of the present invention more clearly, the drawings needed to be used in the description of the embodiments will be briefly introduced below. Obviously, the drawings in the following description are some embodiments of the present invention. Those of ordinary skill in the art can also obtain other drawings based on these drawings without exerting any creative effort.
图1不同菌株AFB1脱毒效率图;Figure 1 Detoxification efficiency chart of AFB1 of different strains;
图2为短乳杆菌(Lactobacillus brevis)ND-1菌落形态以及革兰氏染色剂图,其中,图2a为菌落形态,图2b为革兰氏染色结果,图2c为霉菌抑制图,图2d为无抑制对照图;Figure 2 is a diagram of the colony morphology and Gram stain of Lactobacillus brevis ND-1. Figure 2a is the colony morphology, Figure 2b is the Gram stain result, Figure 2c is the mold inhibition diagram, and Figure 2d is No inhibition control chart;
图3为短乳杆菌(Lactobacillus brevis)ND-1的系统发育树;Figure 3 is the phylogenetic tree of Lactobacillus brevis ND-1;
图4为短乳杆菌(Lactobacillus brevis)ND-1增长速度图;Figure 4 is a graph showing the growth rate of Lactobacillus brevis ND-1;
图5为短乳杆菌(Lactobacillus brevis)ND-1造酸性物质能力图;Figure 5 is a diagram of acid-producing ability of Lactobacillus brevis ND-1;
图6为菌株的不同活性成分以及不同处理对黄曲霉毒素B1解毒效率的影响图,其中,图6a为菌株上清液、裂解内容物和灭活细胞对AFB1脱毒效率图Figure 6 is a diagram showing the effects of different active components of the strain and different treatments on the detoxification efficiency of aflatoxin B1. Figure 6a is a diagram of the detoxification efficiency of AFB1 by the strain supernatant, lysed contents and inactivated cells.
图6b为尿素、溶菌酶和酸处理的短乳杆菌(Lactobacillus brevis)ND-1对AFB1脱毒效率的影响图;Figure 6b shows the effect of Lactobacillus brevis ND-1 treated with urea, lysozyme and acid on the detoxification efficiency of AFB1;
图7为用水和甲醇溶液反复洗涤菌体-AFB1复合物后AFB1解吸率;Figure 7 shows the AFB1 desorption rate after repeated washing of the bacterial cell-AFB1 complex with water and methanol solutions;
图8a为短乳杆菌(Lactobacillus brevis)ND-1随着接种量变化对AFB1的脱毒效率图;Figure 8a is a graph showing the detoxification efficiency of Lactobacillus brevis (Lactobacillus brevis) ND-1 against AFB1 as the inoculum amount changes;
图8b为短乳杆菌(Lactobacillus brevis)ND-1随着时间变化对AFB1的脱毒效率图;Figure 8b is a graph showing the detoxification efficiency of Lactobacillus brevis ND-1 against AFB1 over time;
图8c为短乳杆菌(Lactobacillus brevis)ND-1随着PH值变化对AFB1的脱毒效率图;Figure 8c is a graph showing the detoxification efficiency of Lactobacillus brevis (Lactobacillus brevis) ND-1 against AFB1 as the pH value changes;
图8d为短乳杆菌(Lactobacillus brevis)ND-1随着温度变化对AFB1的脱毒效率图。Figure 8d is a graph showing the detoxification efficiency of Lactobacillus brevis ND-1 against AFB1 as the temperature changes.
具体实施方式Detailed ways
为了能够更清楚地理解本发明的上述目的、特征和优点,下面结合附图和实施例对本发明做进一步说明。需要说明的是,在不冲突的情况下,本申请的实施例及实施例中的特征可以相互组合。In order to understand the above objects, features and advantages of the present invention more clearly, the present invention will be further described below in conjunction with the accompanying drawings and embodiments. It should be noted that, as long as there is no conflict, the embodiments of the present application and the features in the embodiments can be combined with each other.
在下面的描述中阐述了很多具体细节以便于充分理解本发明,但是,本发明还可以采用不同于在此描述的其他方式来实施,因此,本发明并不限于下面公开说明书的具体实施例的限制。Many specific details are set forth in the following description to facilitate a full understanding of the present invention. However, the present invention may also be implemented in other ways than those described here. Therefore, the present invention is not limited to the specific embodiments disclosed below. limit.
实施例,本实施例提供一种短乳杆菌(Lactobacillus brevis)ND-1Example, this example provides a Lactobacillus brevis ND-1
1材料与方法1Materials and methods
1.1样品采集1.1 Sample collection
样品采集自通辽市周边霉菌污染严重的养殖场,主要包括玉米青贮、FTMR以及饲喂上述饲料的牛粪便等。The samples were collected from farms with serious mold pollution around Tongliao City, mainly including corn silage, FTMR, and cow manure fed the above-mentioned feeds.
1.2主要试剂及培养基1.2 Main reagents and culture media
0.01M的磷酸缓冲盐溶液(PBS),AFB1标准品(上海源叶生物科技有限公司),细菌生化鉴定管,AFB1酶联免疫吸附试验(ELISA)检测试剂盒(上海优选生物科技有限公司)MRS液体培养基(北京金克隆生物技术有限公司,pH为6.2±0.1);MRS琼脂培养基(北京金克隆生物技术有限公司,pH为6.2±0.2);马铃薯葡萄糖琼脂培养基(PDA),将培养基在121℃灭菌30min;黄曲霉和寄生曲霉标准菌购自上海源叶生物有限公司。0.01M phosphate buffered saline (PBS), AFB1 standard (Shanghai Yuanye Biotechnology Co., Ltd.), bacterial biochemical identification tube, AFB1 enzyme-linked immunosorbent assay (ELISA) detection kit (Shanghai Youyou Biotechnology Co., Ltd.) MRS Liquid culture medium (Beijing Jinclon Biotechnology Co., Ltd., pH is 6.2±0.1); MRS agar medium (Beijing Jinclon Biotechnology Co., Ltd., pH is 6.2±0.2); Potato dextrose agar medium (PDA), will be cultured The base was sterilized at 121°C for 30 minutes; Aspergillus flavus and Aspergillus parasiticus standard strains were purchased from Shanghai Yuanye Biological Co., Ltd.
1.3菌株筛选1.3 Strain screening
1.3.1乳酸菌的分离纯化1.3.1 Isolation and purification of lactic acid bacteria
在超净工作台中分别称取5g处理后的样品加入到含有95mL无菌水的锥形瓶中,密封,置于37℃、180r/min恒温摇床中振荡富集3h。吸取1ml不同样品上清液稀释至10-5接种到MRS液体培养基,置于37℃培养48h。培养结束各取100μL培养液加入到900μL无菌水中,涡旋振荡,以此梯度稀释至10-8、10-9、10-10三个梯度,分别取不同梯度的菌液100μL涂布于MRS固体培养基中,37℃培养48h。根据菌落形态、颜色、大小等挑取单菌落在培养基上划线,以此方法纯化3次,纯化后的菌株与等体积的甘油混合,置于-20℃冰箱中保存备用。Weigh 5g of the processed samples on the ultra-clean workbench and add them to an Erlenmeyer flask containing 95mL of sterile water, seal it, and place it in a constant temperature shaker at 37°C and 180r/min for 3 hours of shaking and enrichment. Take 1 ml of supernatant from different samples and dilute it to 10-5 to inoculate it into MRS liquid medium and culture it at 37°C for 48 hours. At the end of the culture, add 100 μL of each culture solution to 900 μL of sterile water, vortex, and dilute it to three gradients of 10-8, 10-9, and 10-10. Take 100 μL of each bacterial solution of different gradients and apply it to MRS. In solid medium, culture at 37°C for 48 hours. Pick a single colony according to the colony shape, color, size, etc. and streak it on the culture medium. Purify it three times by this method. The purified strain is mixed with an equal volume of glycerol and stored in a -20°C refrigerator for later use.
1.3.2脱毒AFB1乳酸菌的筛选1.3.2 Screening of detoxified AFB1 lactic acid bacteria
将分离纯化获得的乳酸菌株在MRS液体培养基中进行培养,使菌体细胞浓度达到2.0×1010CFU/mL,培养液10000r/min离心10min后弃去上清液,将菌体沉淀用5ml PBS洗涤两次后重悬于含有AFB1的PBS溶液中,以不接菌的含有AFB1的PBS溶液为空白对照。在37℃条件下培养2h后10000r/min离心10min(10℃),收集上清液500μL保存在-20℃冰箱中待ELISA试剂盒检测。按照ELISA试剂盒提供的方法,计算菌株脱毒效率。The isolated and purified lactic acid strain was cultured in MRS liquid culture medium until the bacterial cell concentration reached 2.0×1010CFU/mL. The culture medium was centrifuged at 10000r/min for 10 minutes and the supernatant was discarded. The bacterial pellet was washed with 5 ml of PBS. After two times, it was resuspended in the PBS solution containing AFB1, and the PBS solution containing AFB1 without bacteria was used as a blank control. After culturing for 2 hours at 37°C, centrifuge at 10,000 r/min for 10 minutes (10°C). Collect 500 μL of the supernatant and store it in a -20°C refrigerator for detection by the ELISA kit. Calculate the strain detoxification efficiency according to the method provided by the ELISA kit.
1.3.3抑制产毒真菌乳酸菌的筛选1.3.3 Screening of lactic acid bacteria that inhibit toxin-producing fungi
采用双层平板法对筛选出具有脱毒作用的乳酸菌进行抑制产毒真菌的测定。先将MRS固体培养基倒入培养皿中作为下层平板,凝固后用接种环蘸取活化至对数期的乳酸菌液在平板上化2条2-3cm的平行线,37℃培养48h至长出菌苔。将含有真菌孢子浓度为106个/ml的PDA培养基倒入培养基中,覆盖在含有乳酸菌菌苔的下层培养基上,30℃条件下培养72h,检测乳酸菌生长条带周围的抑菌圈大小,选择抑菌效果良好的乳酸菌进行后期试验。The double-layer plate method was used to determine the inhibition of toxin-producing fungi by the selected lactic acid bacteria with detoxification effect. First pour the MRS solid culture medium into a petri dish as the lower plate. After solidification, use an inoculating loop to dip the lactic acid bacteria liquid activated to the logarithmic phase into two parallel lines of 2-3cm on the plate. Incubate at 37°C for 48 hours until growth occurs. Bacteria lawn. Pour the PDA culture medium containing fungal spores at a concentration of 106/ml into the culture medium, cover it on the lower culture medium containing the lactic acid bacteria lawn, culture it at 30°C for 72 hours, and detect the size of the inhibition zone around the lactic acid bacteria growth strip. , select lactobacilli with good antibacterial effects for later-stage testing.
1.4菌株鉴定1.4 Strain identification
1.4.1菌落及细菌鉴定1.4.1 Identification of colonies and bacteria
对分离出的乳酸菌菌落形态进行观察,挑取单菌落革兰氏染色后用油镜观察观察菌株形态。挑取菌落并滴加3%过氧化氢溶液,有气泡产生表示为阳性,无气泡产生表示为阴性,并对筛选出的菌株做生理生化试验。The morphology of the isolated lactic acid bacteria colonies was observed, and a single colony was picked for Gram staining and observed with an oil microscope to observe the strain morphology. Pick bacterial colonies and add 3% hydrogen peroxide solution dropwise. The presence of bubbles is considered positive, and the absence of bubbles is considered negative. Physiological and biochemical tests are performed on the selected strains.
1.4.2菌株16S rRNA鉴定1.4.2 Identification of strain 16S rRNA
依据细菌DNA提取试剂盒说明书提取目标菌株DNA,采用试剂盒提供的通用引物:27F(5′-AGAGTTTGATCMTGGCTCAG-3′),1492R(5′-TACGGYTAC CTTGTTACGACTT-3′)。PCR反应体系50μL:5.0μL 10×Ex Taq buffer、4.0μL 2.5mM dNTP Mix、2.0μL10p Primer 1、2.0μL10p Primer 2、0.5μL 5u Ex Taq、2.0μL Template、34.5μL ddH2O。PCR反应条件:94℃预变性3min;94℃变性30s,54℃退火30s,72℃延伸1min30s,共24个循环;72℃终延伸10min。将PCR产物送到北京美优安诺生物科技有限公司测序,测序结果提交到NCBI进行BLAST分析,用MEGA软件中的N-J法构建系统发育树。Extract the DNA of the target strain according to the instructions of the bacterial DNA extraction kit, using the universal primers provided by the kit: 27F (5′-AGAGTTTGATCMTGGCTCAG-3′), 1492R (5′-TACGGYTAC CTGTTACGACTT-3′). 50 μL PCR reaction system: 5.0 μL 10×Ex Taq buffer, 4.0 μL 2.5mM dNTP Mix, 2.0 μL 10p Primer 1, 2.0 μL 10p Primer 2, 0.5 μL 5u Ex Taq, 2.0 μL Template, 34.5 μL ddH2O. PCR reaction conditions: pre-denaturation at 94°C for 3 minutes; denaturation at 94°C for 30 seconds, annealing at 54°C for 30 seconds, extension at 72°C for 1 minute and 30 seconds, a total of 24 cycles; final extension at 72°C for 10 minutes. The PCR products were sent to Beijing Meiyouan Biotechnology Co., Ltd. for sequencing, and the sequencing results were submitted to NCBI for BLAST analysis, and the N-J method in MEGA software was used to construct a phylogenetic tree.
1.5菌株生物学特性测定1.5 Determination of biological characteristics of strains
将高效降解的菌株活化接种于MRS液体培养基中,37℃条件下恒温培养,在第0、2、4、6、8、10、12、14、16、18、20、24、28、32、36h测定菌株发酵液的OD600值,以菌株培养时间为横坐标,OD600值为纵坐标,绘制菌株生长曲线。按照上述方法培养菌株,在第0、2、4、6、8、12、16、24、36、48、72h测定菌液pH,以菌株培养时间为横坐标,pH值为纵坐标,绘制产酸速率曲线。The highly degraded strain was activated and inoculated into MRS liquid culture medium, and cultured at a constant temperature of 37°C. , measure the OD600 value of the strain fermentation broth at 36h, take the strain culture time as the abscissa and the OD600 value as the ordinate, and draw the strain growth curve. Cultivate the strain according to the above method, measure the pH of the bacterial solution at 0, 2, 4, 6, 8, 12, 16, 24, 36, 48, and 72 hours. Take the strain cultivation time as the abscissa and the pH value as the ordinate, and draw the product Acid rate curve.
1.6菌株对AFB1吸附降解情况研究1.6 Study on the adsorption and degradation of AFB1 by bacterial strains
选择对AFB1脱毒能力最高的菌株DN-1作为后续试验菌,将菌株接种于MRS液体培养基中活化至菌体浓度为2.0×1010CFU/ml,将菌液等体积分成3份。其中一份置于4℃冰箱中保存待用,一份DN-1培养液于10000r/min条件下离心20min,上清液用0.22μm水系滤膜过滤后保存备用,菌体沉淀用无菌PBS冲洗2次后重悬于PBS溶液中,利用手持超声细胞破碎仪破碎菌体,4℃、10000r/min离心20min,上清液用0.22μm水系滤膜过滤,得到细胞内容物。最后一份在高压蒸汽灭菌锅中121℃灭菌处理20min。将上述各组菌液于10000r/min条件下离心10min,弃掉上清,用PBS溶液清洗菌体沉淀2次,再用含有AFB1(10μg/mL)的等量无菌PBS重新悬浮菌体,以含有AFB1(10μg/mL)的等量无菌PBS为空白对照,于37℃恒温条件下培养2h,每个样品设置3个重复。培养结束后离心收集上清液用于检测AFB1含量。The strain DN-1 with the highest ability to detoxify AFB1 was selected as the subsequent test strain. The strain was inoculated into MRS liquid culture medium and activated until the bacterial concentration was 2.0×1010CFU/ml. The bacterial solution was divided into three equal volumes. One part is stored in a refrigerator at 4°C for later use. One part of the DN-1 culture medium is centrifuged at 10,000 r/min for 20 minutes. The supernatant is filtered with a 0.22 μm water filter and stored for later use. The bacterial cells are precipitated with sterile PBS. After washing twice, resuspend in PBS solution, use a hand-held ultrasonic cell disrupter to disrupt the cells, centrifuge at 4°C and 10,000 r/min for 20 min, and filter the supernatant with a 0.22 μm water-based filter to obtain the cell contents. The last portion was sterilized in a high-pressure steam sterilizer at 121°C for 20 minutes. Centrifuge the bacterial liquids of each group above for 10 minutes at 10000r/min, discard the supernatant, wash the bacterial pellet twice with PBS solution, and then resuspend the bacterial cells with an equal amount of sterile PBS containing AFB1 (10 μg/mL). An equal amount of sterile PBS containing AFB1 (10 μg/mL) was used as a blank control, and cultured at a constant temperature of 37°C for 2 h. Three replicates were set for each sample. After the culture, the supernatant was collected by centrifugation for detection of AFB1 content.
1.7不同处理及复合物稳定性研究1.7 Study on different treatments and compound stability
将菌株沉淀接种于含有AFB1的PBS溶液中后对其用HCI、尿素和溶菌酶进行不同处理。处理后在37℃条件下培养2h后离心收集上清液测定脱毒率。The strain pellet was inoculated into PBS solution containing AFB1 and then treated with HCI, urea and lysozyme in different ways. After treatment, incubate at 37°C for 2 hours and then centrifuge to collect the supernatant to measure the detoxification rate.
将菌株分为活细胞处理组和灭活细胞处理组,经脱毒试验后10000r/min离心10min得到沉淀,分别以0.5mLPBS(pH7.4)溶液和甲醇溶液重新悬浮菌体,振荡5min提取菌体吸附的AFB1,10000r/min离心20min收集上清液待检测,重复上述步骤3次。The strains were divided into living cell treatment group and inactivated cell treatment group. After the detoxification test, centrifuge at 10000r/min for 10min to obtain the precipitate. The bacteria were resuspended with 0.5mL PBS (pH7.4) solution and methanol solution respectively, and shaken for 5min to extract the bacteria. AFB1 adsorbed by the body was centrifuged at 10000 r/min for 20 min to collect the supernatant for detection. Repeat the above steps three times.
1.8培养条件对菌株AFB1脱毒效率的影响1.8 Effect of culture conditions on detoxification efficiency of strain AFB1
研究不同培养条件对菌株AFB1降解效率的影响,分别设置如下培养条件:接种量(2%、4%、6%、8%、10%);温度(22、27、32、37、42℃);初始pH(4.0、5.0、6.0、7.0、8.0、9.0、10.0);培养时间(1、2、4、8、12、16、20、24、28h)。每个样品设置3个重复,检测AFB1含量变化。To study the impact of different culture conditions on the degradation efficiency of strain AFB1, the following culture conditions were set: inoculum volume (2%, 4%, 6%, 8%, 10%); temperature (22, 27, 32, 37, 42°C) ; Initial pH (4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0); Culture time (1, 2, 4, 8, 12, 16, 20, 24, 28h). Three replicates were set for each sample to detect changes in AFB1 content.
2结果和讨论2 Results and discussion
2.1 AFB1脱毒菌株的分离筛选2.1 Isolation and screening of AFB1 virus-free strains
近年来,乳酸菌脱毒AFB1受到广泛关注,其中多种乳酸菌被证实具有高效AFB1脱毒能力。本试验经连续分离,从样品中共分离到60株乳酸菌株,其中8株具有脱毒AFB1的能力,这8个菌株对AFB1的脱毒能力明显不同,如图1所示。其中菌株DN-1与其它菌株相比表现出最强的脱毒活性(71.38%),QZ-11(64.43%),FY-12(53.13%),FT-9(20.88%),DN-3(45.53%),DN-7(10.57%),FT-1(4.45%),FJ-4(33.47%)。In recent years, the detoxification of AFB1 by lactic acid bacteria has received widespread attention, and a variety of lactic acid bacteria have been confirmed to have efficient AFB1 detoxification capabilities. After continuous isolation in this experiment, a total of 60 lactic acid strains were isolated from the samples, 8 of which had the ability to detoxify AFB1. The ability of these 8 strains to detoxify AFB1 was obviously different, as shown in Figure 1. Among them, strain DN-1 showed the strongest detoxification activity (71.38%) compared with other strains, QZ-11 (64.43%), FY-12 (53.13%), FT-9 (20.88%), DN-3 (45.53%), DN-7 (10.57%), FT-1 (4.45%), FJ-4 (33.47%).
本试验中筛选出的菌株脱毒效率高于上述菌株,这可能是由于菌种差异及霉菌毒素类型不同造成的,另外培养条件的不同也会导致一定差异。The detoxification efficiency of the strains selected in this test is higher than that of the above-mentioned strains. This may be due to differences in bacterial species and types of mycotoxins. In addition, different culture conditions will also lead to certain differences.
2.2 DN-1对产毒真菌的抑制能力2.2 DN-1’s inhibitory ability against toxin-producing fungi
随后对8株菌株进行抑制真菌试验,结果显示,DN-1菌株和FY-12菌株对黄曲霉和寄生曲霉均表现出良好的抑制能力,在真菌附近形成抑菌圈。但由于FY-12菌株对AFB1脱毒率显著低于DN-1菌株(p<0.05),因此选择DN-1菌株进行后续研究。Subsequently, eight strains were tested for fungi inhibition. The results showed that the DN-1 strain and the FY-12 strain showed good inhibitory capabilities against Aspergillus flavus and Aspergillus parasiticus, forming an inhibition zone near the fungus. However, since the AFB1 detoxification rate of FY-12 strain was significantly lower than that of DN-1 strain (p<0.05), DN-1 strain was selected for subsequent research.
表1抑制真菌活性乳酸菌的筛选Table 1 Screening of lactic acid bacteria with fungal inhibitory activity
Note:Strong inhibition+++(formation ofstrong inhibition zonesaroundthe LAB culture);inhibition++(formation ofinhibition zones around theLAB culture);some inhibition+(LAB were not overlaidbythe fungi);absenceofinhibition-(LAB were completely overlaidby fungal growth).Note: Strong inhibition+++(formation of strong inhibition zones around the LAB culture); inhibition++(formation ofinhibition zones around the LAB culture); some inhibition+(LAB were not overlaidby the fungi); absenceofinhibition-(LAB were completely overlaidby fungal growth).
2.3菌株的鉴定2.3 Identification of bacterial strains
DN-1菌株的菌落呈乳白色,表面光滑湿润,半透明,中央凸起,菌落大小为0.2~0.6mm,无芽孢(图2a)。经鉴定DN-1为革兰氏阳性杆菌(图2b)。DN-1的生化特征列于图2中,The colonies of the DN-1 strain were milky white, with a smooth and moist surface, translucent, and a convex center. The colony size was 0.2 to 0.6 mm, and there were no spores (Figure 2a). DN-1 was identified as a Gram-positive bacillus (Fig. 2b). The biochemical characteristics of DN-1 are listed in Figure 2,
通过NCBI数据库中的BLAST搜索(https://blast.ncbi.nlm.nih.gov/Blast.cgi)对获得的16S rRNA基因序列进行分析。The obtained 16S rRNA gene sequences were analyzed by BLAST search in the NCBI database (https://blast.ncbi.nlm.nih.gov/Blast.cgi).
短乳杆菌16S测序结果:Lactobacillus brevis 16S sequencing results:
AGTCGAACGAGCTTCCGTTGAATGACGTGCTTGCACTGATTTCAACAATGAAGCGAGTGGCGAACTGGTGAGTAACACGTGGGAAATCTGCCCAGAAGCAGGGGATAACACTTGGAAACAGGTGCTAATACCGTATAACAACAAAATCCGCATGGATTTTGTTTGAAAGGTGGCTTCGGCTATCACTTCTGGATGATCCCGCGGCGTATTAGTTAGTTGGTGAGGTAAAGGCCCACCAAGACGATGATACGTAGCCGACCTGAGAGGGTAATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCACAATGGACGAAAGTCTGATGGAGCAATGCCGCGTGAGTGAAGAAGGGTTTCGGCTCGTAAAACTCTGTTGTTAAAGAAGAACACCTTTGAGAGTAACTGTTCAAGGGTTGACGGTATTTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGATTTATTGGGCGTAAAGCGAGCGCAGGCGGTTTTTTAAGTCTGATGTGAAAGCCTTCGGCTTAACCGGAGAAGTGCATCGGAAACTGGGAGACTTGAGTGCAGAAGAGGACAGTGGAACTCCATGTGTAGCGGTGGAATGCGTAGATATATGGAAGAACACCAGTGGCGAAGGCGGCTGTCTAGTCTGTAACTGACGCTGAGGCTCGAAAGCATGGGTAGCGAACAGGATTAGATACCCTGGTAGTCCATGCCGTAAACGATGAGTGCTAAGTGTTGGAGGGTTTCCGCCCTTCAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGACCGCAAGGTTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCTACGCGAAGAACCTTACCAGGTCTTGACATCTTCTGCCAATCTTAGAGATAAGACGTTCCCTTCGGGGACAGAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATTATCAGTTGCCAGCATTCAGTTGGGCACTCTGGTGAGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGACGGTACAACGAGTTGCGAAGTCGTGAGGCTAAGCTAATCTCTTAAAGCCGTTCTCAGTTCGGATTGTAGGCTGCAACTCGCCTACATGAAGTTGGAATCGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGCCGGTGAGATAACCTTCGGGAGTCAGCCGTCTAAGGTGAAGTCGAACGAGCTTCCGTTGAATGACGTGCTTGCACTGATTTCAACAATGAAGCGAGTGGCGAACTGGTGAGTAACACGTGGGAAATCTGCCCAGAAGCAGGGGATAACACTTGGAAACAGGTGCTAATACCGTATAACAACAAAATCCGCATGGATTTTGTTTGAAAGGTGGCTTCGGCTATCACTTCTGGATGATCCCGCGGCGTATTAGTTAGTTGGTGAGGTAAAGGCCCACCAAGACGATGATACGTAGCCGACCTGAGAG GGTAATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCACAATGGACGAAAGTCTGATGGAGCAATGCCGCGTGAGTGAAGAAGGGTTTCGGCTCGTAAAACTCTGTTGTTAAAGAAGAACACCTTTGAGAGTAACTGTTCAAGGGTTGACGGTATTTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTTCCGGATTT ATTGGGCGTAAAGCGAGCGCAGGCGGTTTTTTAAGTCTGATGTGAAAGCCTTCGGCTTAACCGGAGAAGTGCATCGGAAACTGGGAGACTTGAGTGCAGAAGAGGACAGTGGAACTCCATGTGTAGCGGTGGAATGCGTAGATATATGGAAGAACACCAGTGGCGAAGGCGGCTGTCTAGTCTGTAACTGACGCTGAGGCTCGAAAGCATGGGTAGCGAACAGGATTAGATACCCTGGTAGTCCATGCCGTAAACGATGA GTGCTAAGTGTTGGAGGGTTTCCGCCCTTCAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGACCGCAAGGTTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCTACGCGAAGAACCTTACCAGGTCTTGACATCTTCTGCCAATCTTAGAGATAAGACGTTCCCTTCGGGGACAGAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTT GGGTTAAGTCCCGCAACGAGCGCAACCCTTATTATCAGTTGCCAGCATTCAGTTGGGCACTCTGGTGAGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGACGGTACAACGAGTTGCGAAGTCGTGAGGCTAAGCTAATCTCTTAAAGCCGTTCTCAGTTCGGATTGTAGGCTGCAACTCGCCTACATGAAGTTGGAATCGCTAGTAATCG CGGATCAGCATGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGCCGGTGAGATAACCTTCGGGAGTCAGCCGTCTAAGGTGA
结果显示,菌株DN-1与短乳杆菌的16S rRNA序列相似度达到99%以上。同时系统发育树结果也显示DN-1与短乳杆菌位于同一分支(图3),因此鉴定为短乳杆菌。The results showed that the 16S rRNA sequence similarity between strain DN-1 and Lactobacillus brevis reached more than 99%. At the same time, the phylogenetic tree results also showed that DN-1 and Lactobacillus brevis were in the same branch (Figure 3), so it was identified as Lactobacillus brevis.
表2.菌株DN-1生理生化实验结果Table 2. Physiological and biochemical experimental results of strain DN-1
Note:“+”,positive;“-”,negative.Note: "+", positive; "-", negative.
2.4菌株生物学特性测定2.4 Determination of biological characteristics of strains
DN-1菌株的生长曲线显示,1-14h为指数生长期,在14h后生长缓慢进入稳定期(图4)。此外,DN-1菌株在发酵0-16h时pH快速下降,在16h时菌液pH较低(<4.0),在发酵0-2h时pH下降速度最快,已经降至5.0以下(图5)。DN-1菌株显示出了良好的生长速率及产酸能力,具有良好的青贮潜力。生长速率和产酸性能是用来评价青贮用乳酸菌的重要指标。生长速度和产酸速度快有利于乳酸菌成为青贮饲料中优势菌种,促进乳酸生成,迅速降低pH,从而抑制其他菌种快速繁殖。植物乳杆菌和短乳杆菌是较常见的青贮用乳酸菌添加剂,前者是同型发酵乳酸菌,能快速产生乳酸降低pH值,后者属于异型发酵乳酸菌,可以产生大量乳酸,有效抑制霉菌生长。The growth curve of the DN-1 strain showed that 1-14h was the exponential growth phase, and the growth slowly entered the stationary phase after 14h (Figure 4). In addition, the pH of the DN-1 strain dropped rapidly during fermentation 0-16h, and the pH of the bacterial liquid was low (<4.0) at 16h. The pH dropped the fastest during fermentation 0-2h, and had dropped below 5.0 (Figure 5) . The DN-1 strain showed good growth rate and acid production ability, and had good silage potential. Growth rate and acid production performance are important indicators used to evaluate lactic acid bacteria for silage. The fast growth rate and acid production rate help lactic acid bacteria become the dominant strain in silage, promote lactic acid production, and quickly reduce pH, thereby inhibiting the rapid reproduction of other bacterial species. Lactobacillus plantarum and Lactobacillus brevis are the more common lactic acid bacteria additives used for silage. The former is a homofermentative lactic acid bacterium that can quickly produce lactic acid to reduce the pH value. The latter is a heterofermentative lactic acid bacterium that can produce a large amount of lactic acid and effectively inhibit the growth of mold.
2.5吸附降解情况研究2.5 Study on adsorption and degradation conditions
菌株去除AFB1的方式主要有两种,通过生物降解或是细胞壁吸附,为了明确脱毒方式,进行由图6a可知,菌株DN-1活细胞的AFB1脱毒率显著高于培养物上清液和裂解内容物(p<0.01),在2h内活细胞脱除了71.79%的AFB1,而培养物上清液和裂解内容物仅分别去除了12.20%和7.79%,这说明在培养过程中菌株DN-1很少分泌降解AFB1的活性物质。同时菌株DN-1灭活细胞反应体系降解率(74.68%)高于活细胞体系,这表明菌株DN-1对AFB1的脱毒方式主要是细胞壁的吸附作用,并且菌株浓度越高,吸附的AFB1越多。乳酸菌通过吸附的方式脱除AFB1。灭活细胞有更高的脱毒率,原因可能是高温灭活导致细胞壁蛋白变性和孔隙变化,从而使更多的活性吸附位点暴露。研究显示,肠黏膜对灭活细胞的吸附性小,基于此这些细胞-毒素复合物可以轻易从肠道清除,并不会残留在肠道。There are two main ways for strains to remove AFB1, through biodegradation or cell wall adsorption. In order to clarify the detoxification method, we can see from Figure 6a that the AFB1 detoxification rate of living cells of strain DN-1 is significantly higher than that of culture supernatant and Lysed content (p<0.01), viable cells removed 71.79% of AFB1 within 2h, while culture supernatant and lysed content only removed 12.20% and 7.79% respectively, which shows that strain DN- 1 rarely secretes active substances that degrade AFB1. At the same time, the degradation rate of the inactivated cell reaction system of strain DN-1 (74.68%) is higher than that of the living cell system, which shows that the detoxification method of strain DN-1 for AFB1 is mainly the adsorption of the cell wall, and the higher the concentration of the strain, the more adsorbed AFB1 more. Lactic acid bacteria remove AFB1 through adsorption. Inactivated cells have a higher detoxification rate. The reason may be that high-temperature inactivation leads to denaturation of cell wall proteins and changes in pores, thereby exposing more active adsorption sites. Studies have shown that the intestinal mucosa has little adsorption capacity for inactivated cells. Based on this, these cell-toxin complexes can be easily cleared from the intestines and will not remain in the intestines.
为了进一步阐明细菌细胞壁的作用,对活细胞进行酸处理、尿素处理和溶菌酶处理。结果显示与活细胞相比,酸处理后的细胞结合AFB1的能力增加至78.35%。尿素和溶菌酶处理后细胞的降解能力显著降低(p<0.01)(图6b),这说明细胞壁对于吸附过程是必要的。研究发现,细胞壁中的肽聚糖、磷壁酸等成分在结合霉菌毒素方面起重要作用,同时细胞壁疏水特性也发挥关键作用。尿素处理后,AFB1的去除率仅为16.27%,原因可能是尿素的抗疏水特性干扰了氢键结合。此外,溶菌酶处理的细胞对AFB1的去除率从71.73%下降到12.35%,这可能与上文提到的肽聚糖三维网络结构完整性有关。To further elucidate the role of the bacterial cell wall, living cells were treated with acid, urea, and lysozyme. The results showed that the ability of acid-treated cells to bind AFB1 increased to 78.35% compared with living cells. The degradation ability of cells was significantly reduced after treatment with urea and lysozyme (p<0.01) (Fig. 6b), which indicates that the cell wall is necessary for the adsorption process. Studies have found that components such as peptidoglycan and teichoic acid in the cell wall play an important role in binding mycotoxins, and the hydrophobic properties of the cell wall also play a key role. After urea treatment, the removal rate of AFB1 was only 16.27%, which may be due to the anti-hydrophobic property of urea that interferes with hydrogen bonding. In addition, the removal rate of AFB1 by lysozyme-treated cells decreased from 71.73% to 12.35%, which may be related to the structural integrity of the peptidoglycan three-dimensional network mentioned above.
2.7吸附稳定性研究2.7 Study on adsorption stability
为了评价活细胞及热灭活细胞与AFB1之间形成的复合物的稳定性,用水和甲醇溶液反复洗涤菌体-AFB1复合物,并检测AFB1解吸率。由图7可知,第1次洗涤过程中AFB1释放量最大,分别为23.07%、34.45%、39.94%和47.39%。相较于活细胞,热灭活细胞具有更高的释放量。而相较于水溶液,甲醇溶液能够释放更多的AFB1。洗脱3次后,菌体AFB1复合物释放量趋于平衡,再洗脱只有微量的AFB1释放出来,菌株DN-1的解吸率维持在40%-50%,说明还具有较高的吸附率。许多研究也证明了乳酸菌与AFB1的结合是一个可逆的过程。In order to evaluate the stability of the complex formed between living cells and heat-killed cells and AFB1, the bacterial cell-AFB1 complex was washed repeatedly with water and methanol solutions, and the AFB1 desorption rate was detected. It can be seen from Figure 7 that the AFB1 release amount was the largest during the first washing process, which were 23.07%, 34.45%, 39.94% and 47.39% respectively. Heat-killed cells have higher release compared to viable cells. Compared with aqueous solutions, methanol solutions can release more AFB1. After 3 times of elution, the amount of bacterial AFB1 complex released tends to be balanced. Only a trace amount of AFB1 is released after further elution. The desorption rate of strain DN-1 is maintained at 40%-50%, indicating that it also has a higher adsorption rate. . Many studies have also proven that the binding of lactic acid bacteria to AFB1 is a reversible process.
这种差异表现除了洗涤液不同,影响霉菌毒素复合物稳定性的因素还包括菌株的种类和菌株结合毒素含量。不同的菌株结合毒素位点具有特异性,同样菌株结合毒素含量越多,菌株吸附稳定性相对较好。结果显示DN-1菌体吸附AFB1是一个可逆的过程,该菌株在洗脱3次后,仍保留较高的去除率。菌体AFB1复合物的稳定性取决于菌株自身的结合能力,具有菌株特异性,在本研究中观察到菌体DN-1吸附AFB1具有较好的稳定性。In addition to different washing solutions, factors affecting the stability of mycotoxin complexes also include the type of strain and the content of toxins bound to the strain. Different strains have specific binding sites for toxins. The more toxins bound to the same strain, the better the adsorption stability of the strain will be. The results show that the adsorption of AFB1 by DN-1 bacteria is a reversible process, and the strain still retains a high removal rate after being eluted three times. The stability of the bacterial AFB1 complex depends on the binding ability of the strain itself and is strain-specific. In this study, it was observed that the bacterial DN-1 adsorbed AFB1 has good stability.
2.8细胞浓度、温度、pH、时间对AFB1脱毒率的影响2.8 Effects of cell concentration, temperature, pH, and time on AFB1 detoxification rate
研究发现,DN-1菌株接种量在0.5%-2.5%时,AFB1的脱毒效率随着接种量增加而增加,最大可达到78.66%,菌株浓度越高,脱毒AFB1越多。而当接种量超过2.5%时脱毒率显著降低(p<0.05)(图8a)。这可能是因为当菌株到达最佳接种量后,继续添加菌株无法充分利用培养基中的能量满足自身生长,从而导致菌株AFB1脱毒率有所降低。因此,菌株DN-1的最佳接种量为2.5%。The study found that when the inoculation amount of DN-1 strain was between 0.5% and 2.5%, the detoxification efficiency of AFB1 increased with the increase of the inoculum amount, reaching a maximum of 78.66%. The higher the strain concentration, the more detoxified AFB1. When the inoculation amount exceeded 2.5%, the detoxification rate decreased significantly (p<0.05) (Fig. 8a). This may be because when the strain reaches the optimal inoculum amount, continued addition of strains cannot fully utilize the energy in the culture medium to meet its own growth, resulting in a decrease in the detoxification rate of strain AFB1. Therefore, the optimal inoculation amount of strain DN-1 is 2.5%.
图8b显示,在0-4h内,DN-1的脱毒率随时间的增加而增加,在4-28h内趋于稳定。AFB1脱毒率在4h和28h之间无显著性差异(p>0.05),结果表明,DN-1菌株的最佳培养时间为4h。在整个试验的28h过程中,超过80%AFB1在前1h被吸附,这说明菌株DN-1吸附AFB1是一个快速的过程,可以在短时间内完成。Figure 8b shows that within 0-4h, the detoxification rate of DN-1 increases with time and tends to be stable within 4-28h. There was no significant difference in AFB1 detoxification rate between 4h and 28h (p>0.05). The results showed that the optimal culture time of DN-1 strain was 4h. During the entire 28h test, more than 80% of AFB1 was adsorbed in the first 1h, which shows that the adsorption of AFB1 by strain DN-1 is a rapid process and can be completed in a short time.
由图8c可知,菌株DN-1能在酸性pH范围内保持较高的AFB1脱毒活性。在pH为4.0-6.0时,随着pH的增大,菌株脱毒效率随之增大。当pH为6.0时,菌株DN-1对AFB1的脱毒率达到最大,为69.13%。当pH大于6.0时,AFB1降解率显著下降(p<0.05)。因此,培养基初始pH为6.0时,菌株DN-1能够发挥最大AFB1降解活性。As shown in Figure 8c, strain DN-1 can maintain high AFB1 detoxification activity in the acidic pH range. When the pH is 4.0-6.0, as the pH increases, the strain detoxification efficiency increases. When the pH was 6.0, the detoxification rate of AFB1 by strain DN-1 reached the maximum, which was 69.13%. When the pH was greater than 6.0, the degradation rate of AFB1 decreased significantly (p<0.05). Therefore, when the initial pH of the culture medium is 6.0, strain DN-1 can exert the maximum AFB1 degradation activity.
图8d显示,当温度处于36℃和40℃时DN-1菌株显示出较高的脱毒率,脱毒率分别为:73.84%、73.27%。两组间AFB1脱毒率无显著性差异(p>0.05)。Figure 8d shows that when the temperature is at 36°C and 40°C, the DN-1 strain shows a higher detoxification rate, and the detoxification rates are: 73.84% and 73.27% respectively. There was no significant difference in AFB1 detoxification rate between the two groups (p>0.05).
3结论3Conclusion
本实施例分离得到了一株能够高效脱毒AFB1的乳酸菌DN-1,经鉴定为短乳杆菌。菌株DN-1主要通过细胞壁的物理吸附作用去除AFB1,在PBS溶液中脱毒效率为71.38%。菌株DN-1具有良好的生长速率及产酸性能,可以作为青贮接种剂的备选菌株。在洗涤3次后,脱毒率仍保持高效。菌株DN-1脱毒AFB1的最适条件为:接种量2.5%,初始pH6.0,温度36℃,培养时间4h。In this example, a strain of lactic acid bacteria DN-1 capable of efficiently detoxifying AFB1 was isolated, which was identified as Lactobacillus brevis. Strain DN-1 mainly removes AFB1 through physical adsorption of the cell wall, and its detoxification efficiency in PBS solution is 71.38%. Strain DN-1 has good growth rate and acid production performance, and can be used as an alternative strain for silage inoculant. After washing 3 times, the detoxification rate remains highly efficient. The optimal conditions for strain DN-1 to detoxify AFB1 are: inoculum volume 2.5%, initial pH 6.0, temperature 36°C, and culture time 4 hours.
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例应用于其它领域,但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。The above are only preferred embodiments of the present invention, and are not intended to limit the present invention in other forms. Any skilled person familiar with the art may make changes or modifications to equivalent changes using the technical contents disclosed above. The embodiments may be applied to other fields, but any simple modifications, equivalent changes, and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still fall within the protection scope of the technical solution of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311056688.0A CN117431171B (en) | 2023-08-22 | 2023-08-22 | Lactobacillus brevis for inhibiting mold and adsorbing and degrading aflatoxin B1 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311056688.0A CN117431171B (en) | 2023-08-22 | 2023-08-22 | Lactobacillus brevis for inhibiting mold and adsorbing and degrading aflatoxin B1 and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117431171A true CN117431171A (en) | 2024-01-23 |
CN117431171B CN117431171B (en) | 2024-09-13 |
Family
ID=89552314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311056688.0A Active CN117431171B (en) | 2023-08-22 | 2023-08-22 | Lactobacillus brevis for inhibiting mold and adsorbing and degrading aflatoxin B1 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117431171B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103205374A (en) * | 2013-03-15 | 2013-07-17 | 厦门和美科盛生物技术有限公司 | Lactic acid bacterium capable of reducing aflatoxin B1 in fermented feed and application of lactic acid bacterium |
CN108570421A (en) * | 2017-03-09 | 2018-09-25 | 北京大北农科技集团股份有限公司 | One lactobacillus plantarum strain and its ensilage fermentation agent |
KR102005433B1 (en) * | 2018-02-22 | 2019-07-30 | 강원대학교산학협력단 | Streptomyces panaciradicis AF34 strain for the degradation of aflatoxin |
CN116426423A (en) * | 2023-03-28 | 2023-07-14 | 武汉轻工大学 | A strain for degrading aflatoxin B1, compound microbial preparation and application thereof |
-
2023
- 2023-08-22 CN CN202311056688.0A patent/CN117431171B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103205374A (en) * | 2013-03-15 | 2013-07-17 | 厦门和美科盛生物技术有限公司 | Lactic acid bacterium capable of reducing aflatoxin B1 in fermented feed and application of lactic acid bacterium |
CN108570421A (en) * | 2017-03-09 | 2018-09-25 | 北京大北农科技集团股份有限公司 | One lactobacillus plantarum strain and its ensilage fermentation agent |
KR102005433B1 (en) * | 2018-02-22 | 2019-07-30 | 강원대학교산학협력단 | Streptomyces panaciradicis AF34 strain for the degradation of aflatoxin |
CN116426423A (en) * | 2023-03-28 | 2023-07-14 | 武汉轻工大学 | A strain for degrading aflatoxin B1, compound microbial preparation and application thereof |
Non-Patent Citations (3)
Title |
---|
EMAN ZAKARIA GOMAA等: "Detoxification of Aflatoxin B1 by Antifungal Compounds from Lactobacillus brevis and Lactobacillus paracasei, Isolated from Dairy Products", 《PROBIOTICS AND ANTIMICROBIAL PROTEINS》, vol. 10, no. 2, 18 November 2017 (2017-11-18) * |
XIAONI WANG等: "Isolation, Characterization, and Biopreservation of Lactobacillus brevis DN-1 to Inhibit Mold and Remove Aflatoxin B1 in Peanut and Sunflower Cakes", 《AGRICULTURE》, vol. 14, 29 April 2024 (2024-04-29) * |
杨玉红;: "乳酸菌对真菌毒素的吸附效果研究", 粮油加工, no. 06, 8 June 2009 (2009-06-08) * |
Also Published As
Publication number | Publication date |
---|---|
CN117431171B (en) | 2024-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108570421B (en) | Lactobacillus plantarum strain and silage starter thereof | |
CN101353633B (en) | Lactobacillus plantarum ZJ316, procreant antibiotic peptides, preparation and use thereof | |
CN114703096B (en) | Bacillus bailii strain, fermented feed degradation microbial toxin thereof and application | |
CN113897319B (en) | Bacillus amyloliquefaciens and application thereof | |
CN114921385B (en) | A kind of Bacillus subtilis and its application in feed addition and antibiotic-free culture | |
CN110387339A (en) | A Strain of Paleobacterium intermedia B522 and Its Application | |
CN110564640A (en) | Siamese bacillus WF2019 strain for degrading aflatoxin B1 and application thereof | |
CN108865940B (en) | A heterotrophic nitrifying-aerobic denitrifying bacillus and its compound bacterial preparation | |
CN102286394A (en) | High-temperature-resisting lactic acid strain HT1 and application in modulation of silage | |
CN110791454A (en) | Efficient ammonia nitrogen degrading strain and application thereof | |
CN114806944A (en) | Lactobacillus plantarum LP11, fermentation liquor thereof, preparation method and application | |
CN110791460A (en) | Strain for inhibiting growth of aspergillus flavus and generation of toxin | |
CN111484958B (en) | Lactobacillus plantarum with ETEC (ethylene-tetra-ethyl-carbonate) inhibition effect, fermentation product and application thereof | |
CN115895934B (en) | A kind of Bacillus belleisi that simultaneously degrades DON and zearalenone and its application | |
CN107502566B (en) | A strain of Bacillus lysine and its application in degrading zearalenone | |
CN114908011B (en) | A kind of Lactobacillus sausage and its application | |
CN116496929A (en) | Bacillus suis and application thereof | |
CN104611255B (en) | One plant height coherency Pediococcus pentosaceus and its application in purifying water body in vibrio parahemolyticus | |
CN114437993A (en) | Lactobacillus reuteri and application thereof in preparation of preparation for preventing diarrhea in cats | |
CN110643553B (en) | Bacterial strain capable of efficiently removing organic matters in water body and application thereof | |
CN117431171B (en) | Lactobacillus brevis for inhibiting mold and adsorbing and degrading aflatoxin B1 and application thereof | |
CN110885767A (en) | A strain of Lactococcus lactis subsp. hallii with good antioxidant activity and its application | |
CN107164280B (en) | A strain of vomitoxin-degrading bacteria and its application | |
CN113355265B (en) | Lactobacillus plantarum and application thereof | |
CN114517170B (en) | Bacillus subtilis for degrading vomitoxin and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |